Stock MURA MURAL ONCOLOGY PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Mural Oncology plc

Equities

MURA

IE000LK2BOB4

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/05/2024 BST 		5-day change 1st Jan Change
3.58 USD -0.28% Intraday chart for Mural Oncology plc -5.04% -39.53%
04-04 Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target MT
01-08 Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
GL
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
AQ
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target
MT
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
GL
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
AQ
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
GL
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
AQ
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
GL
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
AQ
Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials
CI
Mural Oncology plc(NasdaqGM:MURA) dropped from S&P Biotechnology Select Industry Index
CI
Mural Oncology plc(NasdaqGM:MURA) dropped from NASDAQ Biotechnology Index
CI
Mural Oncology plc(NasdaqGM:MURA) added to NASDAQ Composite Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MURA Stock
  4. News Mural Oncology plc